ReviewJournal for immunotherapy of cancer2021

GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors.

David G DeNardo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.